Marias SA

3.0 FTE

Marias reported total assets of 260,517 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 May 2026), with 3 full-time equivalents.

Company number (CBE) 0471.634.091 · VAT BE0471634091
5030 Gembloux
active in Manufacture of dairy products (NACE 10510)
operating since 07 Apr 2000 (≈ 26 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Marias shows with a free account.

See the score
Profile
SA Micro · 3.0 FTE since 2000
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−37,723 €
Equity−180,043 €
Cash1,235 €
EBITDA11,328 €
Total assets260,517 €
Headcount (avg FTE)3.0
Solvency-69.1%
The line marks its sector median: 32.4% (59 companies).

Change 2022 → 2025: Total assets +10 % Headcount (avg FTE) +150 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Marias's annual accounts

20252024202320222021
Net result−37,723 €
Equity−180,043 €
Cash1,235 €
EBITDA11,328 €
Total assets260,517 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 15 May 2026
  • Year ended 30 Jun 2024filed on 30 Jan 2025
  • Year ended 30 Jun 2023filed on 03 Jan 2024
  • Year ended 30 Jun 2022filed on 03 Jan 2024
  • Year ended 30 Jun 2021filed on 07 Feb 2022

Marias's financial analysis

Management and control of Marias

2 active director(s) in the register.

Marias's shareholders and holdings →

Marias's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0471.634.091
VAT number
BE0471634091
Peppol
Registered · 0208:0471634091 · as of 10 Nov 2026
Legal form
SA
Incorporated
07 Apr 2000
Registered office
5030 Gembloux
Size
Micro · 3.0 FTE
Latest accounts
2025 · filed on 15 May 2026
Activity
Manufacture of dairy products (NACE 10510)

Marias (SA) has been based in Gembloux since 2000, active in: manufacture of dairy products. For 2025, it reports a net loss of 37,723 € and equity of −180,043 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -69.1%, below the median of its sector (32.4%).

Companies similar to Marias

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Marias

What is the revenue of Marias?

Marias files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Marias?

In Belgium, the VAT number is the company number prefixed with BE: BE0471634091 for Marias, if the company is VAT-registered. Its company number (CBE) is 0471.634.091.

Where is the registered office of Marias?

According to the CBE register, the registered office of Marias is in 5030 Gembloux.

What is the equity of Marias?

At the close of the 2025 financial year, the equity of Marias amounts to -180,043 €, a solvency of -69.1% of total assets.

How many people work at Marias?

3.0 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Marias?

The register lists 2 active mandates at Marias. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Marias

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗

No credit card, no commitment.

What each plan unlocks →